We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Nanoarray Senses and Distinguishes Multiple Diseases

By LabMedica International staff writers
Posted on 12 Jan 2017
Print article
Image: A diagram of the artificially intelligent nanoarray system to diagnose different diseases from breath analysis (Photo courtesy of the Technion).
Image: A diagram of the artificially intelligent nanoarray system to diagnose different diseases from breath analysis (Photo courtesy of the Technion).
Exhaled breath contains nitrogen, carbon dioxide and oxygen, as well as a small amount of more than 100 other volatile chemical components and the relative amounts of these substances vary depending on the state of a person's health.

An artificially intelligent nanoarray based on molecularly modified gold nanoparticles and a random network of single-walled carbon nanotubes for noninvasive diagnosis and classification of a number of diseases from exhaled breath has been developed.

An international team of scientists led by those at the Technion−Israel Institute of Technology, collected breath samples between January 2011 and June 2014 from 14 departments in nine clinical centers worldwide and were subjected to meta-analysis. The team developed an array of nanoscale sensors to detect the individual components in thousands of breath samples from patients who were either healthy or had one of 17 different diseases, such as kidney cancer or Parkinson's disease.

To transfer exhaled volatile organic compounds (VOCs) the samples underwent thermal desorption (at 250 °C) in a TD20 auto sampler thermal desorption system before they were temporarily stored in a stainless steel VICI sample loop at 150 °C. One of the two breath samples from each subject was analyzed using gas chromatography–mass spectrometry (GC-MS) to determine the chemical nature and composition of the exhaled breath. For this analysis, the Shimadzu GCMS-QP2010 was used combined with their thermal desorption system.

The performance of this artificially intelligent nanoarray was clinically assessed on breath samples collected from 1,404 subjects having one of 17 different disease conditions included in the study or having no evidence of any disease (healthy controls). Blind experiments showed that 86% accuracy could be achieved with the artificially intelligent nanoarray, allowing both detection and discrimination between the different disease conditions examined. Analysis of the artificially intelligent nanoarray also showed that each disease has its own unique breathprint, and that the presence of one disease would not screen out others.

The diagnosis and classification power of the nanoarray was also validated by an independent analytical technique, gas chromatography linked with mass spectrometry. This analysis found that 13 exhaled chemical species are associated with certain diseases, and the composition of this assembly of volatile organic compounds differs from one disease to another. The study was published on December 21, 2016, in the journal ACS Nano.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.